COR vs MCK: fair value comparison
Cencora, Inc. and McKesson Corporation · Updated 2026-08-31
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Healthcare, COR currently sits closer to the top of our discount ranking. MCK carries the stronger momentum grade.
| COR | MCK | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $322.03 | $893.39 |
| 12-month range | $264.69–$372.65 | $691.62–$990.95 |
| Sector rank | #73 of 113 Healthcare | #78 of 113 Healthcare |
| Quality grade | F | F |
| Momentum grade | C | B |
| Leverage | High | Low |
| Margin trend | Stable | Stable |
| Revenue growth | Strong | Strong |
| RSI zone | Neutral | Neutral |
| DCF cross-check | — | Undervalued |
| 52-week position | The upper-middle quarter | The upper-middle quarter |
Full single-stock breakdowns: COR fair value analysis · MCK fair value analysis